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ABSTRACT
Background: Diabetic nephropathy (DN) is one of the microvascular 
complications of diabetes and almost the leading cause of end-stage 
kidney failure in the world, responsible for morbidity and mortality. 
Currently the management strategy for DN consists of antihypertensive 
and antiproteinuric measures but these therapies have been 
suboptimal. Many herbs have been recommended for treating DN as 
an adjuvant therapy. However, the recommendations are mostly based 
on animal studies. Thus, the evidences about their mechanisms and 
clinical usefulness are limited.
Purpose: This review focused on the medicinal herbs which can treat DN. 
Method: The search was done in PubMed, Science Direct, Scopus, Web 
of Science and Google Scholar databases a 15-year period between 
2004 to 2019 with keywords search of medicinal plant, plant extract, 
diabetic nephropathy, Traditional Chinese medicine.
Results: According to the results, many plants showed positive 
effects but Astragalus polysaccharides, Panax Notoginoside, Berberine 
had the best DN treatment effects with exact mechanisms of action. 
Conclusion: It seems that using these medicinal plants or the extraction 
of their active ingredients as complementary therapeutics will improve 
the management of DN in patients.
Keywords: Medicinal plants; Phytochemical; diabetic nephropathy; Mechanism; Traditional Chinese medicine.
INTRODUCTION
Diabetes mellitus is a chronic metabolic disorder 
caused by either absolute deficiency in insulin 
secretion or reduction in the biological effec-
tiveness of insulin (C. W. Park, 2014). Diabetic 
nephropathy (DN) caused by diabetes mellitus is 
one of the major causes of end-stage renal failure 
worldwide (International Diabetes Federation, 
2015). Clinically, microalbuminuria is an essential 
index which can be used to assess the progression 
of DN. It is one of the microvascular complica-
tions of diabetes and almost the leading cause of 
end-stage kidney failure in the world, responsi-
ble for morbidity and mortality (T. Scully, 2012). 
Diabetic patients are always on a high risk of devel-
oping diabetes related complications like hyper-
tension, neuropathy, nephropathy, retinopathy, 
stroke and others (S. Bell et al., 2015). The clinical 
manifestations of DN include increasing initial 
glomerular filtration rate (GFR), proteinuria, 
increasing creatinine levels and decreasing GFR 
eventually (Elsherbiny NM and AlGayyar MM, 
2016). Diagnosis of different stages of diabetic 
nephropathy is based on functional renal evalua-
tion (Table 1) (M Shlomo rt al., 2011).
Major pathological changes of DN include 
mesangial expansion, extracellular matrix (ECM) 
accumulations, tubulointerstitial fibrosis and 
glomerular sclerosis (J. Skupien et  al., 2012). The 
pathogenesis of DN can be summarized by three 
distinctive mechanisms. First, there is an expansion 
of mesangial membrane because of the prolonged 
hyperglycemia which leads to heightened creation 
of matrix and/or glycosylation of the proteins in 
the matrix. Second, the coagulating of the glomer-
ular cellar tissue will be resulted because of various 
inflammatory processes. Third, there is an expan-
sion of the afferent artery or ischemic wound caused 
by the contraction of blood vessels innervating the 
glomerular apparatus due to hyaline deposition.
In addition, Diabetic nephropathy is divided into 
four hierarchical glomerular lesions mentioned in 
Table 2 (T. W. C. Tervaert et al., 2010).
To deal with the burden of diabetes and its 
related complications including DN, research into 
novel therapies to treat DN is expanding. Currently 
the management strategy for DN consists mainly of 
antihypertensive and antiproteinuric measures that 
depend on strict RAAS inactivation (A. K. H. Lim, 
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2014). However, these traditional therapies have 
been suboptimal.
Chinese herbal medicine is both Chinese wealth 
and world’s treasure. Through constant exploration, 
Chinese people accumulate the wisdom of Chinese 
medicine in the long process of practice. A lot of 
effective chemicals from Chinese herbal medicine 
have been confirmed to treat diabetes, such as alka-
loids, flavonoids, polysaccharides and saponins. 
Chinese herbal medicine exerts almost none, if any 
side effects in patients, therefore attracting more 
and more attentions (X.-L. Tong et  al., 2012). In 
this review, we provide a relatively comprehensive 
discussion on Chinese herbal medicine regard-
ing their main active components and functional 
mechanisms in the treatment of diabetes nephrop-
athy. The search was done in PubMed, Science 
Direct, Scopus, Web of Science and Google Scholar 
databases a 15-year period between 2004 to 2019 
with keywords search of medicinal plant, plant 
extract, diabetic nephropathy, Traditional Chinese 
medicine. Attempts have been done to make the 
best knowledge of their mechanisms and effects. 
The medicinal herbs are grouped by different part 
of plants such as Root, Entire Plant with roots, 
Rhizome, Sporocap, Fruits and Leaves. 
APPLICATIONS OF TCM IN DN
Root:
Salvia miltiorrhiza (SM)
Salvia miltiorrhiza, which is commonly known as 
danshen, is a traditional Chinese medicine used for 
treating cardiovascular and inflammatory diseases. 
It has been shown to have organ protective, anti-in-
flammatory, and anti-oxidative effects.In a study 
performed by Sang-Hun Lee et al., the progression 
of renal function deterioration in DN rats could 
be decreased by SM as it inhibited the expressions 
of ED-1, RAGE, TGF-β1 and collagen IV (Sang-
Hun Lee et al, 2011). In another study, it has been 
revealed that the renoprotection of danshen injec-
tion on DN rat was related to the preservation of 
tubular function and structure from the hypergly-
cemia induced toxicities of inappropriate cytokines 
secretion, oxidative stress, advanced glycation 
stress and megalin expression deletion. (DengKe 
Yin et al. 2014)
Catalpol
In traditional Chinese medicine, Catalpol is an 
iridoid glycoside isolated from Rehmanniae gluti-
nosa (RG) which is used to treat diabetic disorder. It 
is suggested that Catalpol could eliminate extracel-
lular matrix accumulation by restraining TGF-β1, 
CTGF and Ang II expression. This could amelio-
rate the early diabetic nephropathy (Zhao Dong 
et  al., 2013). It is also found that Catalpol could 
down-regulate Grb10 expression and activate insu-
lin-like growth factor 1/insulin-like growth factor 1 
receptor (IGF-1/IGF-1R) signaling pathway which 
in turn ameliorated DN in mice (Shasha Yang et al., 
2016).The total glycosides of RG, which is extracted 
from RG, could prevent DN to develop and occur 
by regulating TGF-β1 protein expression level in 
renal tissue and mesangial cells. (Dai X et al., 2018)
Triptolide
Triptolide, which is an active diterpene purified 
from Tripterygium Wilfordii Hook F(TWH), is 
used to treat rheumatoid arthritis. It has been 
showed that albuminuria and renal lesion with 
dyslipidemia and obesity could be attenuated by 
triptolide (Qing Gao et  al., 2010). By inhibiting 
TNF-α and TGF-β1 overexpression in the kidney, 
the macrophage infiltration in glomeruli was 
reduced and p38 MAPK and NF-κB signaling activ-
ities were suppressed respectively. Thus, DN could 
be alleviated by multi-glycoside of TWH (Wei Wu 
et al.,2017). According to Xing-gang DONG et al., 
triptolide could protect against DN by down-regu-
lating the expression of OCP in the renal cortex of 
DN rats (Xing-gang DONG et al., 2017)
Panax Notoginoside
It is a main active compound of Panax notogin-
seng saponins (PNS) which is used to promote 
the blood circulation in traditional Chinese medi-
cine. It is indicated that PNS had the function of 
protecting kidney from diabetes through up-reg-
ulating SIRT1. Also, it inhibited inflammation by 
reducing the induction of inflammatory cytokines 
and TGF-β1. Moreover, antioxidant proteins in 
rats could be activated by PNS (DU Yue-guang 
et al., 2016). A study group found that PNS could 
inhibit the expression of TGF-β1 protein and 
enhance the expression of Smad7 protein which 
protects the kidney of diabetic rats as a result (TU 
Qing-nian et al., 2011). They also showed that PNS 
could enhance the expression of BMP-7 protein in 
the kidney and suppress the expression of VEGF 
protein so that the kidneys of Type 1 diabetic mice 
could be protected (Qingnian TU et  al.,2011). 
Another major component in Panax notoginseng is 
Notoginsenoside R1(NR1). According to Guodong 
Huang et  al. (2016), podocyte injury in DN rats 
could be ameliorated by NR1 by inhibiting both 
the process of apoptosis and inflammation through 
the PI3K/Akt signaling pathways (GUODONG 
HUANG et al., 2016). 
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Astragalus polysaccharides (APS)
In traditional Chinese medicine, Radix astragali is 
the dried root of astragalus membranaceus (Fisch.) 
Bunge which is widely and commonly applied. 
Astragalus polysaccharide (APS) is one of the aque-
ous extracts from Astragalus membranaceus root. It 
is suggested that APS could lower blood glucose level 
and reduce DN. As it decreased NF-κB expression 
and increased IκB expression, APS could be used 
to prevent early stage DN. (Ying-Wen Zhang et  al., 
2007). In other study, the administration of astraga-
lus injection could rebalance TGFβ/SMAD signaling 
pathway and prevent DN (Yanna Nie et  al.,2014). 
Astragaloside IV(AS-IV), which is one of the essen-
tial active ingredients of astragalus membranaceus 
(Fisch) Bunge, could protect podocyte and ameliorate 
DN by suppressing the expression of integrin-linked 
kinase (ILK) and restoring the expression of integrin 
α3β1 in diabetic rats (Jianguo Chen et al., 2014). In 
similar study, AS-IV is useful for ameliorating DN 
progression in Type 2 DM which may be related to the 
inhibition of Akt/mTOR, NFκB and Erk1/2 signaling 
pathways (SUN, Huili, et  al., 2016). Another study 
group demonstrated that AS-IV could inhibit tubular 
epithelial transdifferentiation and prevent or mitigate 
DN. This could protect DN rats from renal damage 
(Yuee YI et al., 2016). It is also suggested that AS-IV 
could hinder DN progression in Type 2 diabetes mice 
which may be related to restoring the mitochondrial 
quality control network (Xinhui Liu et al., 2017). Also, 
it is showed that AS-IV protected against podocyte 
injury via SERCA2-dependent ER stress reduction and 
AMPKα-promoted autophagy induction (Hengjiang 
Guo et  al., 2017). Besides, it is demonstrated that 
AS-IV could decrease the excretion of urinary albu-
min and ameliorate functional and structural abnor-
malities of diabetic kidneys through suppressing renal 
cortical phosphorylation of MEK1/2-ERK1/2-RSK2 
signaling (Gaofeng Song et al., 2018).
Paeoniflorin
Extracting from the dried peeled root of Paeonia 
lactiflora Pall, it is a major bioactive component 
which could improve the inflammatory status of 
DN in diabetic mice by inhibiting the Toll-like 
receptor-2(TLR2) signaling pathway (Yun-xia Shao 
et al., 2017). It is highlighted that Paeoniflorin could 
prevent macrophage activation through inhibiting 
TLR2/4 signaling expression in Type 2 diabetic 
nephropathy (Tingmin Zhang et al., 2017).
Puerarin
It is an active ingredient of Radix puerariae which 
is a traditional Chinese herbal medicine that used 
to treat kidney diseases such as acute kidney injury, 
nephrotoxicity and nephropathy. Apart from prov-
ing that it has the function to reduce oxidative 
stress and suppress matrix metalloprotectinase 
9(MMP-9), it is showed that Puerarin could attenu-
ate podocyte injury and proteinuria in diabetic rats 
(ZHONG, Yifei, et al.,2014). In similar study, it is 
demonstrated that Puerarin could attenuate eNOs 
expression in glomerular endothelial cells and 
tubular cells and improve renal function of diabetic 
mice (ZHANG, Yong, et  al.,2015). Particularly, it 
has been shown in a study that Puerarin exerted 
anti-oxidative effects through activating SIRT1-
mediated NF-κB deacetylation. As a result, Puerarin 
attenuated early diabetic kidney injury through 
down-regulating MMP-9(LI, Xueling, et al., 2017).
Moutan Cortex (MC)
It is a root bark of Paeonia suffruticosa Andr 
which can be used to treat inflammatory diseases. 
According to Ming-Hua Zhang et  al. (2014), MC 
had the protective effect on DN-caused inflam-
mation of AGEs-induced rat mesangial cells and 
DN rats through the intervention on AGEs and 
RAGE (ZHANG, Minghua, et  al., 2014). Besides, 
this study group also showed that MC could atten-
uate oxidative stress in AGEs-induced mesangial 
cell dysfunction and in STZ-induced DN rats due 
to its antioxidant activity (ZHANG, Ming-hua, 
et  al.,2014). Terpene glycoside (TG) is a major 
component of Moutan Cortex. It is demonstrated 
that TG inhibited IRE1/NF-κB activation which in 
turn improved the condition of endoplasmic retic-
ulum stress-related inflammation in DN rats (Juan 
Chen et al., 2016).
Table 1  The classic five stages of diabetic nephropathy based on 
functional renal evaluation
Stage 1 hypertension GFR BP
Stage 2 Silent GFR BP
Stage 3 Microalbuminuria GFR BP
Stage 4 Macroalbuminuria GFR BP
Stage 5 End-stage renal disease (ESRD) GFR BP
GFR: glomerular filtration rate; BP: Blood pressure
Table 2  Diabetic nephropathy is divided into four hierarchical 
glomerular lesions
Class Description
I Mild or nonspecifc changes on light microscopy and conformed GBM 
thickening proven by electron microscopy: GBM > 395 nm (female), GBM 
> 430 nm (male)
IIa Mild mesangial expansion in >25% of the observed mesangium; area of 
mesangial proliferation < area of capillary cavity
IIb Severe mesangial expansion in >25% of the observed mesangium. Area of 
mesangial proliferation < area of capillary cavity
III At least one convincing nodular sclerosis (Kimmelstiel-Wilson lesion)
IV Advanced diabetic glomerulosclerosis in >50% of glomeruli
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Table 3 Applications of single herbal TCM and/or monomers in DN
Species Extract DN model Duration Pathways Result
Root
Salvia 
miltiorrhiza 
danshen STZ rat 8 weeks Through slowing the 
progression of renal function 
deterioration. (Sang-Hun 
Lee, et al. 2011)
Reducing TGF-β1, collagen IV, ED-1, and 
RAGE.
Radix Salvia 
miltiorrhiza
the aqueous 
extracts of Danshen
STZ rat 8 weeks Through preservating 
tubular function and 
structure. (DengKe Yin, et al. 
2014) 
Ameliorating UAlb, sCr, and BUN; alleviating 
the ultrastructural abnormalities of 
hypertrophy, matrix expansion, and fibrosis in 
glomerulus; decreasing the TGF-β1 expression, 
AGEs and LPO accumulation; increasing the 
activity of SOD and GSH-Px.
Rehmannia 
glutinosa
Catalpol STZ rat 14 days Through down-regulating 
Grb10 expression up-
regulation of IGF-1/IGF-1R 
signaling. (Yang S, et al. 
2016)
improving impaired renal functions; 
ameliorating pathological changes in kidneys; 
abrogating the elevated Grb10 expression; 
increasing IGF-1 mRNA levels and IGF-1R 
phosphorylation.
Rehmannia 
glutinosa 
Libosch (RG)
catalpol STZ rat 10 weeks Through reducing the 
extracellular matrix 
accumulation. (Zhao Dong, 
et al. 2013) 
Reducing the KWI; improving the kidney 
function and pathological change; decreasing 
the tissue level of Ang II, TGF-β1, CTGF, 
FN, Col IV; down-regulating the mRNA 
expressions of TGF-β1 and CTGF in renal 
cortex.
Rehmannia 
glutinosa 
Libosch (RG)
the total glycosides 
of RG
STZ rat 15 days Through inhibiting TGF-β1 
and Wnt/β-catenin signaling 
pathway. (Dai X, et al. 2018)
Restoring pentose, glucuronate 
interconversion, terpenoid backbone 
biosynthesis, purine metabolism and retinol 
metabolism; preventing high glucose-induced 
GMCs.
Tripterygium 
wilfordii Hook 
F(TWH)
Triptolide db/db mice 12 weeks Through attenuating the 
inflammation and oxidative 
stress. (Qing Gao, et al.2010)
Attenuating UAlb; alleviating glomerular 
hypertrophy and podocyte injury.
Tripterygium 
wilfordii Hook 
F(TWH)
Multi-glycoside of 
TWH
STZ rat 8 weeks Through exerting anti-
microinflammatory effects. 
(WEI WU, et al. 2017)
improving biochemical parameters without 
affecting hyperglycemia; attenuating GS; 
suppressing the infiltration of ED1+ cells in 
glomeruli and the protein overexpression 
of TNF-α, IL-1β and TGF-β1; inhibiting 
the protein overexpression of key signaling 
molecules of p38 MAPK and canonical NF-κB 
pathways.
Tripterygium 
wilfordii Hook 
F(TWH)
Triptolide STZ rat 4 weeks Through down regulating 
the expression of OCP in 
the renal cortex. (Xing-gang 
DONG, et al. 2017)
Decreasing 24-h UAE, renal MDA and NT 
expression; Decreasing renal OCP; elevating 
renal SOD.
Panax 
notoginseng
Panax notoginseng 
Saponins
alloxan rat 3 months Through up-regulating 
SIRT1 and inhibiting 
inflammation. (DU Yue-
guang, et al. 2016)
Reducing FBG; increasing protein level 
of BMP-7; inhibiting PAI-1 expression; 
suppressing the transcription of TGF-β1 and 
MCP-1; reverse the increased acetylation of 
NF-κB p65 by high glucose; down-regulating 
MDA.
Panax 
notoginseng
Panax 
Notoginoside
STZ rat 6 weeks Through down-regulating 
TGF-β1/Smad signaling 
pathway. (TU Qing-nian, 
et al. 2011)
Decreasing FBG, Ccr and UAlb; Decreasing 
the expression of TGF-β1 protein in renal 
tissues; increasing the expression of Smad7 
protein.
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Table 3 Continue
Species Extract DN model Duration Pathways Result
Panax 
notoginseng
Panax 
Notoginoside
STZ rat 4 weeks Through regulating of VEGF 
and BMP-7 expressions. 
(Qingnian TU, et al.2011)
Decreasing sCr, Ccr, and UAlb; increasing 
protein level of BMP-7; decreasing the 
expression of VEGF protein.
Panax 
notoginseng
Notoginsenoside 
R1
STZ rat 16 weeks Through activating the 
PI3K/Akt signaling pathway 
and inactivating NF-κB. 
(GUODONG HUANG, et al. 
2016)
Ameliorating histological alterations; 
increasing the expression of nephrin and 
podocin; decreasing the expression of desmin; 
inhibiting the inflammatory response and the 
apoptosis of podocytes.
Astragalus 
membranaceus
Astragalus 
polysaccharide
stz rat 8 weeks Through decreasing the 
mRNA level of NF-κB in 
renal cortex; raising IκB 
mRNA expression. (Ying-
Wen Zhang, et al. 2007)
Ameliorating shineless, bristly hair, polyuria, 
polydipsia, lethargy, physical inactivity, loss of 
body weight, kyphosis and decubitus position 
of DN mice; lowering FBG, plasma lipid and 
UAlb; reducing K/B ratio; improving the renal 
function.
Astragalus 
membranaceus
astragalus injection KKAy 
mice
10 weeks Through inhibiting TGFβ/
Smad signaling. (Yanna Nie, 
et al. 2014)
Reducing UA1b; improving renal function; 
ameliorating changes in renal histopathology; 
increasing Smad7 expression; decreasing the 
mRNA level of TGF-β1.
Astragalus 
membranaceus
Astragaloside IV stz rat 14 weeks Through up-regulating 
integrin α3β1 and inhibiting 
ILK. (CHEN, Jianguo, et al. 
2014)
ameliorated podocyte loss, renal 
histopathology and podocyte foot process 
effacement; Reducing UA1b; improving cell–
matrix adhesion of podocytes to GBM.
Astragalus 
membranaceus
Astragaloside IV db/db mice 12 weeks Through inhibiting Akt/
mTOR, NFκB and Erk1/2 
signaling pathways. (SUN, 
Huili, et al. 2016)
Reducing UA1b; ameliorating changes in the 
glomerular and tubular pathology; decreasing 
urinary NAG, NGAL and TGF-β1.
Astragalus 
membranaceus
astragalus injection KKAy 
mice
24 weeks Through suppressing 
tubular epithelial 
transdifferentiation. (Yue-e 
Yi, et al. 2016)
Reducing FBG; inhibiting morphological 
changes in the kidneys; reducing mRNA 
and protein expression levels of TGF-β1, 
TGFβ-R1, and α-SMA; increasing E-cadherin 
in expression.
Astragalus 
membranaceus
Astragaloside IV 
(AS-IV)
db/db mice 12 weeks Through restoring the 
mitochondrial quality 
control network. (LIU, 
Xinhui, et al. 2017)
Reducing UAE and urinary NAG; ameliorating 
the renal pathologic injury; reducing 
renal Drp-1, Fis1, and MFF expression; 
downregulating PINK1/Parkin-mediated 
mitophagy.
Astragalus 
membranaceus 
Astragaloside IV 
(AS-IV)
stz rat 8 weeks Through ER stress 
attenuation mediated by 
SERCA2 restoration and 
autophagy enhancement 
promoted by AMPKα 
activation. (GUO, Hengjiang, 
et al. 2017)
Attenuating diabetes or HG-induced podocyte 
apoptosis, paralleled by a marked remission 
in ER stress and a remarkable restoration in 
impaired autophagy; improving the expression 
of SERCA2b and AMPKα phosphorylation.
Astragalus 
membranaceus
astragaloside IV 
(AS-IV)
stz rat 8 weeks Through inhibiting the 
MEK1/2-ERK1/2-RSK2 
signaling. (SONG, Gaofeng, 
et al. 2018)
Reducing UA1b and sCr; ameliorating 
mesangial matrix expansion and greater foot 
process width; decreasing the levels of uNAG, 
NGAL and TGF-β1.
Paeonia 
lactiflora Pall
Paeoniflorin stz rat 12 weeks Through inhibiting the TLR2 
pathway. (SHAO, Yun-xia, 
et al. 2017)
Reducing UA1b; attenuating renal 
histopathology; alleviating macrophage 
infiltration.
Paeonia 
lactiflora Pall
Paeoniflorin db/db mice 2 weeks Through inhibiting the 
TLR2/4 signaling expression. 
(ZHANG, Tingmin, et al. 
2017)
Decreasing UAE; inhibiting macrophage 
infiltration and activation.
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Table 3 Continue
Species Extract DN model Duration Pathways Result
Radix 
puerariae
puerarin stz rat 8 weeks Through exerting the 
anti-oxidative effects in 
podocytes. (ZHONG, Yifei, 
et al. 2014)
Attenuating UA1b and diabetic kidney injury; 
reducing oxidative stress and reducing NOX4 
expression in glomeruli; reducing superoxide 
production; increasing both mRNA and 
protein levels of SIRT1 in podocytes.
Radix 
puerariae
Puerarin stz rat 4 weeks Through regulating eNOS 
expression. (ZHANG, Yong, 
et al.2015)
Improving body weight, FBG, BUN and sCr 
levels; reducing ultrastructural changes of 
kidney; attenuating eNOS expression. 
Radix 
puerariae
Puerarin stz rat 7 days Through suppressing 
oxidative stress production 
and S-nitrosylation of 
proteins. (LI, Xueling, et al. 
2017)
Attenuating kidney hypertrophy,mesangial 
expansion,UA1b,and podocyte foot process 
effacement; increasing the expression of 
podocytes lit diaphragm proteins;suppressing 
MMP-9.
Paeonia 
suffruticosa 
Andr.
Moutan Cortex stz rat 1 month Through intervention on 
AGEs and RAGE. (ZHANG, 
Minghua, et al. 2014)
inhibiting AGEs-induced migration of 
macrophages; improving FBG, sCr and UA1b; 
suppressing IL-6, MCP-1, TGF-β1, ICAM-1 
and RAGE.
Paeonia 
suffruticosa 
Andr.
Moutan Cortex stz rat 1 month Through attenuating 
oxidative stress. (ZHANG, 
Ming-hua, et al.2014)
Increasing the activity of SOD, GSH-PX, and 
CAT;reducing MDA,LPO;decreasing FBG, 
sCr, UA1b;downregulating TGF-β2 protein 
expression in renal tissue.
Paeonia 
suffruticosa 
Andr.
TG component 
from Moutan 
Cortex
stz rat 1 month Through inhibiting IRE1/ 
NF-κB activation. (CHEN, 
Juan, et al.2016)
Improving renal insufficiency and pathologic 
changes; down-regulating ER stress-related 
factors GRP78/Bip, XBP-1(s) levels; reducing 
the pro-inflammatory molecules IL-6, MCP-1, 
and ICAM-1 expressions.
Anemarrhena 
asphodeloides 
Bunge
Mangiferin stz rat 12 weeks Through inhibiting the 
TGF-β1 pathway. (LI, Xuan, 
et al.2010)
improving the renal function of DN rats; 
decreasing effect on 24 h UAE; increasing Ccr; 
inhibiting overexpression of TGF-β1, AGE and 
ECM accumulation, polyol pathway activation, 
ROS generation and MCs proliferation.
Anemarrhena 
asphodeloides 
Bunge
Timosaponin B-II alloxan-
induced 
mice
4 weeks Through inhibiting TXNIP, 
mTOR, and NF-κB signaling 
pathways. (YUAN, Yong-
liang, et al.2015)
Decreasing FBG; ameliorating renal 
histopathological injury; decreasing kidney 
index, BUN, sCr, urinary uric acid, UCr, 
UA1b; reducing lipid metabolism levels of 
TC and TG and the levels of inflammatory 
cytokines IL-6 and TNF-α.
Eucommia 
ulmoides 
Oliver barks
Eucommia bark stz rat 20 days Through inhibiting TGF-β/
Smad signaling. (NIU, Ho-
Shan, et al.2016)
Decreasing the plasma levels of BUN and 
UCr; improving renal fibrosis; attenuating 
the higher expressions of protein levels of 
TGF-β and CTGF; reducing the increased 
phosphorylation of Smad2/3.
Entire Plant with roots
Houttuynia 
Cordata 
Thumb
Houttuynia 
Cordata Thumb
STZ rats 8 weeks Through decreasing the 
expression of TGF-β1 and 
collagen I. (WANG, F, 
et al.2007)
Reducing the overgrowth of glomerulus, the 
excretion of β2-MG in 24-hr urine,UAE and 
CCR; increasing BMP-7.
Coreopsis 
tinctoria Nutt 
(AC)
ethyl acetate extract 
of AC
stz rat 4 weeks Through inhibiting AMPKα 
and the TGF-β1/Smad 
signaling pathway. (YAO, 
Lan, et al.2015)
reducing FBG, TC, TG, BUN,sCr 
,UA1b,expression of kidney proinflammatory 
cytokines of MCP-1 and ICAM-1; 
ameliorating renal hypertrophy and fibrosis by 
reducing FN and collagen IV and suppressing 
the TGF-β1/Smad signaling pathway.
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Flos 
Abelmoschus 
manihot(TFA)
Total Flavone 
Glycosides of TFA
stz rat 24 weeks Through preventing renal 
damage and podocyte 
apoptosis. (ZHOU, Lei, 
et al.2012)
Decreasing ACR and 24-h UA1b; improving 
glomerular cell apoptosis; mitigating cultured 
podocyte apoptosis induced by AGEs; 
inhibiting caspase-3 and caspase-8 expressions 
induced by AGEs.
Abelmoschus 
manihot (L.) 
medic
Huangkui capsule stz rat 8 weeks Through down-regulating 
the activation of p38MAPK 
and/or Akt pathways as well 
as the expressions of TGF-β1 
and/or TNF-α. (MAO, Zhi-
Min, et al.2015)
ameliorating body weight, kidney weight, 
UA1b and renal function including BUN and 
SUA; attenuating renal fibrosis; attenuating OS 
indicators including MDA, SOD, 8-OHdG and 
NADPH oxidase 4, but did not lower blood 
glucose. 
Averrhoa 
carambola L. 
(Oxalidaceae)
2-dodecyl-6-
methoxycyclohexa-
2,5-diene-1,4-dione
KKAy 
mice
8 weeks Through attenuating AGE 
expression and
downregulating the NF-κB 
-TGF-β1 pathway. (ZHENG, 
Ni, et al.2013)
Decreasing FBG,renal AGE formation, AGE 
receptor, NF-kB, TGF-β1,CML; attenuating 
diabetes-dependent alterations in UA1b, sCr, 
UCr, serum urea-N and glomerular mesangial 
matrix expansions; enhancing the activities of 
SOD and GSH-Px.
Averrhoa 
carambola L. 
(Oxalidaceae) 
(±)- Lyoniresinol 
3α-O-β-D-
Glucopyranoside
stz rat 14 days Through increasing ISI 
and improving IR. (WEN, 
Qingwei, et al.2013)
Decreasing FBG, NF-κB, caspase-3, -8, -9, and 
Bax; improving diabetes-dependent alterations 
in the kidney such as glomerular hypertrophy, 
excessive extracellular matrix amassing, and 
GBM thickening; enhancing Bcl-2 expression.
 Hydrangea 
paniculata
Skimmin stz rat 17 weeks Through down-regulating 
TGF-β1 signaling pathway. 
(ZHANG, Sen, et al.2012)
decreasing the sCr and glucose level; 
increasing UCr; decreasing glomerulus 
segmented sclerosis and incidence of tubule 
vacuolar degeneration; down-regulating the 
TGF-β1 and TGF-β1 Receptor I. 
Herba 
artemisiae 
capillaris 
(HAC)
herba artemisiae 
capillaris extract 
(HACE)
stz rat 12 weeks Through inhibiting ECM 
accumulation. (GENG, 
Jianan, et al.2018)
Decreasing FBG and blood lipid; improving 
renal functions; inhibiting oxidative stress 
through regulating enzymatic activity; 
increasing the ECM degradation through 
regulating the activity of MMP-2 and the 
expression of tTG.
Rhizome
Coptidis 
rhizoma 
and Cortex 
Phellodendri
berberine stz rat 8 weeks Through modulating the 
proteins expression of GRKs 
in G protein-AC-cAMP 
signaling pathway. (WANG, 
Feng Ling, et al.2013)
Decreasing UCr, UP24 h,UMAlb, BUN, sCr; 
improving K/B ratio;retarding mesangial 
expansion, glomerulosclerosis,GBM 
thickening; increasing cAMP levels; down-
regulating GRK2, GRK3 and up-regulating 
GRK6 of renal cortex.
Coptidis 
rhizome 
and Cortex 
phellodendri
berberine KKAy 
mice
16 weeks Through inhibiting the 
Notch/snail pathway. 
(YANG, Guannan, 
et al.2017)
Reducing FBG and 24-hUA1b; ameliorating 
degradation of renal function; normalizating 
index of renal interstitial fibrosis and K/B; 
suppressing the activation of the Notch/snail 
pathway and upregulating the α-SMA and 
E-cadherin levels.
Rhizoma 
coptidis
Berberine stz rat 12 weeks Through inhibiting renal 
fibrosis. (LI, Zhong, et al. 
2017)
Reducing kidney injury; inhibiting the protein 
and mRNA expression levels of TGF-β, 
vimentin and αSMA.
Cortex 
Phellodendri 
Chinensis
Berberine stz rat 20 weeks Through inhibiting NF-κB 
and TGF-β/ Smad3 signaling 
pathway. (SUN, Si‐Fan, 
et al.2015)
reducing serum levels of FBG and lipids; 
inhibiting UA1b; attenuating renal histological 
injuries; inhibiting renal inflammation; 
inhibiting IL-1b, TNF-α, MCP-1; suppressing 
renal fibrosis including expression of FN, 
collagen I, and collagen IV.
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Ligusticum 
chuanxiong
tetramethylpyra-
zine
STZ rat 8 weeks Through downregulating 
expression of VEGF. (YANG, 
Qi-Hong, et al.2011)
Improving blood glucose and renal function; 
downregulating the expression of VEGF.
Rheum 
palmatum L. 
(rhubarb)
Emodin stz rats 3 weeks Through suppressing 
inflammation, ICAM1 and 
Bax; activating the PI3K/
Akt/GSK-3β pathway. (JING, 
Danqing, et al.2017)
Attenuating FBG,UAE,sCr,TII scores; 
normalizing kidney weight; inhibiting 
inflammationrelated factors and oxidative 
stress; suppressing ICAM-1, Bax; increasing 
phosphorylated Akt and p-GSK-3β; inhibiting 
caspase-3 activity.
Rheum 
palmatum L. 
(rhubarb)
emodin KK-Ay 
mice
8 weeks Through inhibiting the 
PERK-eIF2α signaling 
pathway. (TIAN, Nianxiu, 
et al. 2018)
ameliorating UA1b, sCr, and BUN; increasing 
nephrin expression; reducing podocytes 
apoptosis and GRP78 level; decreasing the 
expression of P-PERK, phosphorylated 
P-eIF2α, ATF4, and CHOP.
Rheum 
palmatum L. 
(rhubarb)
Rhein db/db mice 12 weeks Through decreasing lipid 
levels and protect against DN 
progression. (GAO, Qing, 
et al.2010)
Decreasing UAE,Chol,TG,LDLC,ApoE,levels 
of ECM; decreasing 
TGF-β1,fibronectin immunohistochemistry 
expression in renal tissue.
Turmeric 
(Curcuma 
longa)
Curcumin stz rat 8 weeks Through regulating the 
functional connections 
between cav-1 
phosphorylation and ROS. 
(SUN, Li-na, et al.2016)
Attenuating abnormalities in HG-treated 
podocytes; improving the renal function; 
suppressing ROS levels, oxidative stress, 
apoptosis and cav-1 phosphorylation.
Turmeric 
(Curcuma 
longa)
Curcumin stz rat 56 days Through resuming 
downregulation of Wnt/ 
β-catenin signaling. (HO, 
Cheng, et al.2016)
 Alleviating HG induction of superoxide; 
alleviating UA1b and serum superoxide 
level; reducing 8-OHdG, TGF-β1 and FN; 
restoring suppressed Wnt5a expression 
immunoreactivities in glomeruli; alleviating 
ECM in DN.
Turmeric 
(Curcuma 
longa)
B6, an analog of 
curcumin
stz rat 8 weeks Through enhancing the 
level of ACE2. (XU, Xuegu, 
et al.2018)
Reducing sCr, BUN, UA1b; decreasing 
the level of AngII; improving the renal 
pathological changes; increasing the levels of 
ACE2 and ACE2 mRNA.
Lycopus 
lucidus Turcz
The aqueous extract 
of Lycopus
stz rat 30 days Through inhibiting TGF-β1 
signaling pathway. (YAO, 
Yuanzhang, et al.2013)
suppressing rhTGF- β1-induced Smad2 and 
ERK1/2 activation; down-regulating TGF-RI, 
TGF-RII, Smad4 and Smad7; reducing mRNA 
level of TGF- β1; ameliorating expansion of the 
mesangial area in glomerular tissue; reducing 
sCr, BUN, total-SOD activity.
Rhodiola 
Rosea(RR)
Ethanol Extrac of 
RR
stz rat 8 weeks Through inhibiting TGF-β1 
signaling pathway. (WANG, 
Zhi-sen, et al.2013)
Reducing FBG, TC, TG, Ccr, UA1b, the 
ratio of K/B and glomerular area; decreasing 
TGF-β1 expression in renal tissues.
Sporocap(Others)
Auricularia 
auricular (AA)
Polysaccharides 
of AA 
stz rat 8 weeks Through modulating the 
antioxidative system and the 
NFκB signaling pathway. 
(HU, Xinyu, et al.2017)
Reducing FBG by promoting glucose 
metabolism; modulating SOD, GSH-Px, ROS 
and MDA levels in serum; regulating BUN, 
sCr, UA1b and inflammatoryrelated factors.
Ophiopogon 
japonicus
MDG-1 KKAy 
mice
12 weeks Through inhibiting 
intracellular signaling 
pathways. (WANG, Yuan, 
et al.2015)
Decreasing the levels of FBG, TC, BUN and 
UA1b; inhibiting the expression of TGF-β1 
and connective tissue growth factor; alleviating 
glomerular mesangial expansion and 
tubulointerstitial fibrosis.
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Taxus 
chinensis
Taxus chinensis stz rats 8 weeks Through suppressing 
TGF-β1/Smad signaling 
pathway. (HONG-BO 
WENG, et al.2018)
Decreasing 24-h UAE, sCr, and BUN; reducing 
GBM thickness; attenuating mesangial cells 
and podocytes cells proliferation and the 
increase in mesangial matrix; down-regulating 
TGF-β1, α-SMA; inhibiting phosphorylation 
of Smad2 and Smad3.
Inonotus 
obliquus (IO)
Polysaccharides 
of IO
stz rat 8 weeks Through inhibiting NF-
κB/TGF-β1 signaling 
pathway. (CHOU, Yen-Jung, 
et al.2016)
Less insulin tolerance; reducing TG; elevating 
HDL/LDL ratio; decreasing ACR; restoring 
the integrity of the glomerular capsules and 
increase the numbers of GMCs, associated 
with decreased expression of TGF-β1 on renal 
cortex.
Fruits
Corni Fructus 
(PC)
Loganin stz rat 12 weeks Through inhibiting 
AGE pathway. (LIU, Kai, 
et al.2015)
Reducing K/B ratio, UA1b, BUN and sCr; 
improving the histology of pancreas and 
kidney; alleviating the structural alterations 
in endothelial cells, mesangial cells and 
podocytes in renal cortex; reducing MDA and 
increased the levels of SOD. 
Corni Fructus 
(PC)
Iridoid Total 
Glycoside of PC
stz rats 12 weeks Through preventing AGE-
induced activation of 
prosclerotic cytokines. (XU, 
Hui-Qin, et al.2004)
Decreasing serum protein level and glomerular 
mRNA expression of TGF-β1; preventing renal 
overdeposition of FN and LM.
Corni Fructus 
(PC)
Morroniside of PC STZ rats 20 days Through inhibiting 
AGE-RAGE binding. 
(YOKOZAWA, Takako, 
et al.2008)
increasing UA1b, total protein; reducing 
BUN, sCr; reducing the enhanced levels 
of serum glycosylated protein, serum and 
renal thiobarbituric acid-reactive substances; 
decreasing AGE level, CML, receptors for 
AGE, HO-1.
Corni Fructus 
(PC) 
components in PC stz rat 12 weeks Through regulating the 
number and function of 
podocytes. (LIU, Hong, 
et al.2012)
Decreasing FBG, NAG, mALB; increasing INS, 
WT1EI; improving renal damage; reducing the 
renal morphology score.
Rosa laevigata 
Michx(RLM)
The aqueous 
extracts of RLM
stz rat 2 months Through inhibiting NF-κB-
MCP-1-dependent pathway. 
(ZHOU, Yujuan, et al.2012)
Ameliorating renal dysfunction; increasing 
SOD activity and total antioxidant capacity; 
decreasing MDA and ROS; inhibiting the 
expression of NF-κB and MCP-1.
Schisandra 
chinensis fruit
Schisandra 
chinensis fruit 
extract
stz rat 9 weeks Through blocking EMT-
like phenotypic changes in 
podocytes via repressing 
transcription factor snail. 
(ZHANG, Mianzhi, 
et al.2012)
Decreasing UAE and ACR; Attenuating 
glomerulosclerosis and protected against 
podocyte loss and integrity of the slit 
diaphragm; Preventing the EMT of podocytes.
Alpinia 
oxyphylla
Alpinia oxyphylla 
Miq. extract
db-/db-
mice
8 weeks Through changing the 
expressions of specific 
miRNAs. (DU, Guankui, 
et al.2017) 
Lowering FBG, UA1b, UCr; The putative 
target genes of 7 miRNAs were associated with 
T2DM, renal cell carcinoma, AMPK, PI3K-
Akt signaling pathway.
gardenia 
jasminoides
Genipin stz rat 12 weeks Through inhibiting UCP2 
expression. (QIU, Wenjing, 
et al.2012) 
Ameliorating body weight loss, UA1b; 
attenuating GBM thickness; restoring the 
podocyte expression of podocin and WT1; 
suppressing the up regulation of UCP2.
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Leaves
Leaves of 
Cyclocarya 
paliurus
Extract of leaves of 
Cyclocarya paliurus
stz rat 5 weeks Through protecting 
pancreatic β cells from 
apoptosis via modulating 
MAPK and Akt signaling 
pathways. (XIAO, Hai-tao, 
et al.2017)
Inhibiting pancreatic β cell apoptosis by 
suppressing the expression of caspase 8, 
caspase 9, cleaved caspase-3, Bax/Bcl-
2 ratio; down-regulating p38, ERK and 
JNK phosphorylation; up-regulating Akt 
phosphorylation.
Lycium 
barbarum(LB)
Polysaccharide 
of LB
stz rat 8 weeks Through down-regulating 
NF-𝜅B activation. (DU, 
Mingzhao, et al.2016)
Ameliorating bodyweight loss; reducing FBG, 
UA1b, BUN and serum levels of inflammatory 
factors including IL-2, IL-6, TNF-𝛼, IFN-𝛼, 
MCP-1, and ICAM-1; enhancing activities of 
SOD and GSH-Px in serum.
Lycium 
chinense leaves
Lycium chinense 
leaves extract
stz rat 40 days Through suppressing 
renal oxidative stress and 
inflammation. (OLATUNJI, 
Opeyemi Joshua, et al.2018)
Reducing the serum levels of Cr, BUN, UA1b 
and TGF-β1; Reducing the elevated levels 
of renal oxidative stress markers and pro-
inflammatory parameters (GSH, SOD, CAT, 
MDA, TNF-α, IL-6 and IL-1β.
Herba 
epimedii
Icariin stz rat 8 weeks Through modulating the 
expression of collagen IV 
and TGF-β1 protein. (QI, 
Min-You, et al.2011)
Attenuating the enhancement of Cr and BUN; 
Remitting the elevated MDA and Hyp levels as 
well as decreased SOD activities; Ameliorating 
the renal pathological changes in renal tissue.
Mangiferin
It is a polyphenol from Anemarrhena asphodeloi-
des Bge. which was used as a useful cardioprotective 
agent. It is showed that Mangiferin could prevent 
progression of DN significantly and improve 
renal function through hindering overexpression 
of TGF-β1, AGE and ECM accumulation, ROS 
generation, polyol pathway activation and MCs 
proliferation (LI, Xuan, et al., 2010). Timosaponin 
B-II (TB-II) is a main steroidal saponin constituent 
that can be found in Anemarrhena asphodeloides 
Bunge. It has the function of anti-inflammatory 
and hypoglycemic. A study group found that TB-II 
regulated mTOR, NF-κB, TXNIP signaling path-
ways and eliminated diabetic renal injury (YUAN, 
Yong-liang, et al., 2015).
Eucommia bark (Du-Zhong)
In China, Eucommia ulmoides Oliver barks is a 
well-known tonic herb which has the properties of 
improving kidney circulation and liver detoxifica-
tion. It is suggested that Du-Zhong could hinder 
TGF-β/connective tissue growth factor expression 
and suppress TGF-β /Smad signaling (Ho Shan Niu 
et al., 2016).
ENTIRE PLANT WITH ROOTS
Houttuynia Cordata Thumb (HCF)
It is a famous traditional Chinese medicine 
which has the function of anti-oxidation and 
 anti-inflammation. In a study performed by Wang 
Feng et  al., HCF could safeguard renal tissues in 
diabetic mice due to its ability to increase BMP-7 
in renal tissues and decrease TCF-β1 and collagen I 
expression (Wang Feng et al., 2007).
Coreopsis tinctoria Nutt
In traditional Chinese medicine, the dry flowers 
of this plant can be used to reduce the occurrence 
of diabetes and cardiovascular disease. It has been 
showed that the ethyl acetate extract of C.tinctoria 
Nutt could activate phosphorylation of AMPKα in 
the kidneys and inhibit TGF-β1/Smad pathway. 
This could then better control blood glucose level 
and hinder inflammatory and fibrotic processes 
(Lan Yao et al.,2015).
Flos Abelmoschus manihot (TFA)
In traditional Chinese medicine, Flos Abelmoschus 
manihot is a well-known medicine that used to treat 
inflammatory disease. It has been demonstrated 
that TFA could reduce urinary albumin excre-
tion and minimize renal damage in STZ-induced 
DN mice at the early stage as it could ameliorate 
podocyte apoptosis (Lei Zhou et al., 2012). Also, it 
is showed that TFA could down-regulate the acti-
vation of p38MAPK and/or Akt pathway and the 
expression of TGF-β1 and/or TNF-α in the kidney 
as it is renoprotective through reducing oxidative 
stress and renal fibrosis in DN mice (Zhi-Min Mao 
et al., 2015).
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2-Dodecyl-6-methoxycyclohexa-2,5- 
diene-1,4-dione (DMDD)
The dry root of Averrhoa carambola L. (ACLR) 
is commonly used in traditional Chinese medi-
cine to treat diabetic mellitus and eliminate its 
complications. It is suggested that DMDD, which 
is separated from Averrhoa carambola L. roots, 
could treat diabetic mellitus through reducing 
hyperglycemia by attenuating AGE expression 
and  down-regulating NF-κB-TGF-β1 pathway in 
diabetic glomeruli (Zheng et  al., 2013). A study 
group found that (±)- Lyoniresinol 3α-O-β-D- 
Glucopyranoside (LGP1, LGP2) were two chiral 
lignin glucosides that were separated from ACLR. 
They could decrease FINS and FBG levels in DN 
mice as they inhibited the cysteine protease caspase 
family (Qingwei Wen et al., 2013).
Skimmin
It is mainly found in the water extract of branches 
and stems of Hydrangea paniculates. Results of the 
study showed that skimmin could decrease the rate 
of renal fibrosis and inhibit DN in rats through 
regulating TGF-β1 signaling pathway (Sen Zhang 
et al., 2012).
Herba Artemisiae Capillaris Extract (HACE) 
Herba artemisiae capillaris (HAC) is a traditional 
Chinese herbal medicine used to protect liver. 
According to Jianan Geng et al., HACE inhibited the 
DN progress by cleaning ROS and eliminating the 
accumulation of ECM (Jianan Geng et al., 2018).
RHIZOME
Berberine (BBR)
It is an isoquinoline alkaloid isolated from Coptidis 
rhizome and Cortex phellodendri which are used 
to treat gastroenteritis and secretory diarrhea. By 
modulating the protein expressions of GRKs in 
G protein-AC-cAMP signaling pathway, it is showed 
that BBR exerted renoprotection in STZ-induced DN 
rats (Feng Ling Wang et al., 2013). In another study, it 
is also indicated that BBR could suppress renal tubu-
lar EMT and renal interstitial fibrosis through Notch/
snail pathway regulation (Guannan Yang et al., 2017). 
Besides, it has been revealed that BBR could inhibit 
fibrosis and ameliorate DN symptoms (Zhong Li 
et al., 2017). Furthermore, it is found that BBR could 
attenuate type 2 DN by inhibiting NF-κB and TGF-β/ 
Smad3 signaling pathway (Si-Fan Sun et al., 2015).
Tetramethylpyrazine
It is a compound that is extracted from the 
rhizome of a famous Chinese medicine ligusticum 
chuanxiong. Qi-Hong Yang et al. (2011) suggested 
that it could down-regulate the expression of vascu-
lar endothelial growth factor in the kidney. This 
may eliminate the damaging effect of diabetes on 
kidney (Qi-Hong Yang et al., 2011).
Emodin
Because of its anti-inflammatory effect, Emodin 
is always used to suppress inflammation. It is an 
anthraquinone derivative isolated from the root 
of rheum Palmatum L(rhubarb). It is showed that 
Emodin could suppress inflammation, ICAM-1 
and Bax, and activate PI3K/Akt/GSK-3β pathway. 
This in turn protected against DN (Dan Qing Jing 
et  al., 2017). In similar study, it has been demon-
strated that Emodin inhibited PERK-eIF2α signal-
ing pathway in vivo and in vitro as well as mitigated 
podocytes apoptosis (Nianxiu Tian et  al., 2018). 
Rhein is another active component purified from 
rhubarb. It is found that lipid levels of DN rats 
could be decreased by Rhein. It could also protect 
against DN progression in a different fashion with 
simvastatin (Qing Gao et al., 2010).
Curcumin
It is an active ingredient of the natural turmeric 
(Curcumalonga) which has a wide spectrum of 
pharmacological activities. It is demonstrated 
that being able to regulate the functional connec-
tions between cav-1 phosphorylation and ROS, 
Curcumin could weaken high glucose-induced 
podocyte apoptosis in vitro and in vivo (Li-Na SUN 
et  al., 2016). By preventing the diabetes-mediated 
superoxide synthesis and resuming downregulation 
of Wnt/B-catenin signaling pathway, Curcumin 
could ease extracellular matrix accumulation in 
DN. (ChengHo et  al., 2016) B6 is an analog of 
Curcumin. It is suggested that B6 upregulated 
ACE2 and ACE2mRNA, thus it could protect the 
renal function of diabetic rats (Xuegu Xu et  al., 
2018).
Lycopus lucidus Turcz
In traditional Chinese medicine, it has an ability to 
remove blood stasis and promote blood circulation. 
It is showed that the aqueous extract of Lycopus 
lucidus Turcz could block TGF-β1 pathway and 
ameliorate DN (Yuanzhang Yao et al., 2013).
Rhodiola Rosea
It is a plant of the Crassulaceae family. It is indi-
cated that Rhodiola Rosea extract could reduce 
the TGF-β1 expression in renal tissue and induce 
a protective effect on early DN in diabetic mice 
(Zhi-sen Wang et al., 2013).
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SPOROCAP (OTHERS)
Auricularia auricular (AA)
Auricularia auricular polysaccharide (AAP) is a 
polysaccharide separated from AA which is one of 
the most vital artificial cultivation mushrooms. A 
study group suggested that AAP could adjust the 
anti-oxidative system and nuclear factor kappa 
β-related signaling pathway. This could induce the 
anti-nephritic and anti-diabetic effects (Xin Yu Hu 
et al., 2017).
MDG-1
It is a famous Chinese medicine that can treat 
cardiovascular disease and diabetes. It is indi-
cated that MDG-1 could ameliorate renal disease 
in diabetic rats and it was a polysaccharide from 
Ophiopogon japonicas. It inhibited intracellular 
signaling pathways and reduced hyperinsulinemia, 
hyperlipidemia and hyperglycemia (Yuan Wang 
et al., 2015).
Taxus Chinensis
It is a plant which belongs to the taxaceae family. A 
study suggested that Taxus chinensis could inhibit 
TGF-β1/Smad signaling pathways and ease renal 
injuries in DN mice (Weng Hong-Bo et al., 2018).
Inonotus obliquus polysaccharides (LIOP)
It is a polysaccharide which is separated 
from Inonotus obliquus. Belong to the family 
Hymenochaetaceae, Inonotus obliquus is a white rot 
fungus. According to Jung chou et al., by inhibiting 
NF-κB/TGF-β1 signaling pathway, glucolipotoxic-
ity-induced renal fibrosis in diabetic nephropathy 
rats could be ameliorated by LIOP (Jung chou et al., 
2016).
FRUITS
Loganin
Loganin is a primary bioactive component of 
Cornus officinalis which has been used in Chinese 
medicine to treat diabetes traditionally. It is showed 
that loganin could ameliorate diabetic nephropathy 
in vivo by suppressing the pathways of AGE (Kai Liu 
et al., 2015). The results of Hui Qin Xu et al. study 
suggested that iridoid total glycoside from Cornus 
officinalis could prevent ACE-induced activation of 
prosclerotic cytokines such as TGF-β1 and prevent 
overdeposition of ECM. As such, it could be used 
in treating and preventing DN. (Hui Qin Xu et al., 
2004). Morroniside is a compound separated from 
Corni Fructus.A study found that it could inhibit 
hyperglycemia and oxidative stress, prevent-
ing renal damage in diabetes mellitus (Takako 
Yokozawa et al., 2008).It has been mentioned that 
the best compatibility of components in Corni 
Fructus had protective effect on early nephropathy 
in type 2 diabetic rats because of the regulation of 
the number and function of podocytes (Hong Liu 
et al., 2012).
Rosa laevigata Michx (RLM)
It is an evergreen climbing shrub which is used to 
treat chronic urinary tract infections and anti-ox-
idative treatment in traditional Chinese medicine. 
It is found that RLM could eliminate OS, suppress 
NF-κB and MCP-1 expression, and improve the 
metabolism of lipid and glucose. Thus, functional 
and historical abnormalities of DN mice were 
improved. (Yujuan Zhou et al., 2012).
Schisandra chinensis fruit extract (SE)
In traditional Chinese medicine, it is an herb which 
is extracted from the fruits of Schisandra chinensis. 
In a study performed by Mianzhi zhang et al., SE 
could inhibit epithelial-to-mesenchymal transition 
(EMT), preserve the integrity of podocyte and 
attenuate glomerulosclerosis as well as albuminuria 
(Mianzhi zhang et al. ,2012).
Alpinia oxyphylla Miq (AOE)
In traditional Chinese medicine, the fruit of AOE 
are used to treat inflammation, intestinal disorders 
and cancer. In a study performed by Guankui Du 
et  al., AOE helped to improve the condition of 
diabetes by changing specific miRNAs expression 
(Guankui Du et al., 2017).
Genipin
It is a glycine derived from an iridoid glycoside 
in the fruit of gardenia jasminoides which is used 
to lighten the condition of diabetes in Chinese 
Medicine. It has been revealed that genipin could 
suppress mitochondrial uncoupling protein 
2(UCP2) expression and improve the condition 
of podocyte injury in DN rats (Wenjing Qiu et al., 
2012).
LEAVES
Cyclocarya paliurus tea leaves
In traditional Chinese Medicine, the leaves of 
C.paliurus have been used to treat obesity and 
diabetes for a long time. Results of the study 
showed that C. paliurus tea leaves could suppress β 
cell apoptosis and promote pancreatic β cell preser-
vation (Hai Tao Xiao et al., 2017).
Lycium barbarum Polysaccharide (LBPS)
Lycium barbarum is a medicinal plant which 
possesses the properties of immunoregulation, 
anti-tumor and hepatoprotection. LBPS is an active 
186 Discovery Phytomedicine 2019; 6(4): 174-190. doi: 10.15562/phytomedicine.2019.108 www.phytomedicine.ejournals.ca
Review of Traditional Chinese ... Jack Hei WAN, et al.
compound separated from Lycium barbarum. It 
is suggested that LBPS had the anti-diabetic and 
anti-nephritic effect which were closely related to 
anti-inflammatory activities and NF-κB mediated 
antioxidant (Mingzhao Du et al., 2016).
Lycium chinense leaves extract 
The leaves of L.Chinense are commonly used to 
nourish and eliminate the risk of arteriosclerosis. 
In a study performed by Opeyemi Joshua Olatunji 
et al., the extract of the leaves of lyceum chinense 
increased antioxidant enzyme activity and attenu-
ated inflammation to suppress oxidative stress. This 
might be potential pharmacological agent against 
DN (Opeyemi Joshua Olatunji et al., 2018).
Icariin
It is a main active flavonoid glucoside isolated from 
Epimedium brevicornum Maxim. It is often used 
in the treatment of diabetic mellitus. Particularly, it 
has been shown in a study that icariin modulated 
the expression of collagen IV and TGF-β1 protein 
and eliminated renal damage in DN mice (Min You 
Qi et al., 2011).
CONCLUSIONS AND PERSPECTIVES
In this review, we aimed to present a summary of 
the main medicinal plants and their active ingredi-
ents which can treat DN. The applications of single 
herbal TCM and/or monomers in DN are summa-
rized in Table 3. Also, some important mechanisms 
of Medicinal Plants to treat DN are concluded in 
Figure 1. According to Figure 2, most monomers 
from single herbal TCM treating DN come from 
roots. This imply that we may discover more herbal 
Figure 2  Distributions of single herbal TCM and/or monomers in DN: 
Figure 1  Medicinal plants in treatment of diabetic nephropathy with their mechanism of actions
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medicine which have specific protective effect on 
DN in future study. In this review, we found that 
many monomers such as Astragalus polysaccha-
rides, Panax Notoginoside, Berberine have specific 
treatment effects on DN. Among these monomers, 
the highest number of research papers focus on 
is Astragalus polysaccharides. It seems that using 
these plants as complementary therapeutics will 
improve the management of DN patients. Although 
many plants have been studied for treating DN, only 
a small fraction has been tested in clinical trials. 
Therefore, it is important to conduct placebo-con-
trolled and randomized controlled clinical trials of 
monomers from herbal TCM in the future study to 
develop their therapeutic potentials for DN.
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ABBREVIATIONS
ACE2, angiotensin-converting enzyme II; ACR, 
urinary albumin/creatinine ratio; AGEs, advanced 
glycation end products; AMPKα, AMP-activated 
protein kinase α; AngII, angiotensin II; ApoE, 
apolipoprotein E; ATF4, activating transcrip-
tion factor 4; β2-MG, β2-microglobin; BMP-7, 
bone morphogenetic protein-7; BUN, blood urea 
nitrogen; CAT, catalase; cav-1, Caveolin-1; Ccr, 
creatinine clearance rate; Chol, cholesterol; CHOP, 
CCAAT-enhancer-binding protein homologous 
protein; CML, polyclonal anti-N e-(carboxymethyl)
lysine; Col IV, collagen type IV; CTGF, connective 
tissue growth factor; DN, diabetic nephropathy; 
Drp-1, dynamin-related protein 1; ECM, extra-
cellular matrix; ED-1, monocyte/macrophage; ER, 
endoplasmic reticulum; EMT, epithelial-to-mesen-
chymal transition; eNOS, endothelial nitric oxide 
synthases; FBG, fasting blood glucose; Fis1, mito-
chondrial fission protein 1; FN, fibronectin; GBM, 
glomerular basement membrane; GMC, glomer-
ular mesangial cells; Grb10, Growth factor recep-
tor-bound protein 10; GRP78: glucose regulated 
protein 78; GRKs, G protein-coupled receptor 
kinases; GS, glomerulosclerosis; GSH, glutathi-
one; GSH-Px, glutathione peroxidase; HDL/LDL, 
high-density lipoprotein cholesterol/ low-density 
lipoprotein cholesterol; HG, high glucose; HO-1, 
rabbit polyclonal IgG heme oxygenase-1; Hyp, 
hydroxyproline; ICAM-1, intercellular adhesion 
molecule 1; IFN-𝛼, interferon-𝛼; IGF-1R, insu-
lin-like growth factor 1 receptor; IL-1β, interleu-
kin-1β; IL-2, interleukin-2; IL-6, interleukin-6; 
INS, Insulin; IR, insulin resistance; ISI, insulin 
sensitivity index; K/B, kidney/body weight ratio; 
KWI, kidney weight index; LDLC, low density 
lipoprotein cholesterol; LM, laminin; LPO, lipid 
peroxide; mALB, Microalbuminuria; MCP-1, 
monocyte chemoattractant protein-1; MCs, 
mesangial cells; MDA, malondialdehyde; MFF, 
mitochondrial fission factor; MMP-2, metallopro-
teinase-2; MMP-9, matrix metalloproteinase-9; 
NADPH, nicotinamide adenine dinucleotide 
phosphate oxidase 4; NAG, urinary N-acetyl-β-
d-glucosamine-dase; NF-κB, B-cell lymphoma 
2-associated X protein; NF-κB, nuclear factor κB; 
NGAL, neutrophil gelatinase-associated lipocalin; 
NOX4, NAPDH oxidase 4; NT, nitrotyrosine; OCP, 
oxidative carbonyl protein; PAI-1, Plasminogen 
activator inhibitor-1; P-eIF2α, phosphorylated 
eukaryotic initiation factor 2α; p-GSK-3β, phos-
phorylated-glycogen synthase kinase 3; p38MAPK, 
p38 mitogen-activated protein kinase; PINK1, 
PTEN-induced putative kinase 1; P-PERK, phos-
phorylated protein kinase rna-like endoplasmic 
reticulum kinase; RAGE, receptor of advanced 
glycation end-products; ROS, Reactive oxygen 
species; sCr, serum creatinine; SERCA2b, sarco-
endoplasmic reticulum Ca2+ ATPase 2b; SOD, 
superoxide dismutase; SUA, serum uric acid; TC, 
Total Cholesterol; TGF-β1, transforming growth 
factor-β1; TGFβ-R1, transforming growth factor 
beta receptor 1; TG, triglycerides; TII, tubulointer-
stitial injury index; TNF-𝛼, tumor necrosis factor-𝛼; 
tTG, tissue transglutaminase; UAE, urinary albu-
min excretion; UCP2, uncoupling protein 2; UCr, 
urine creatinine; UMAlb, urine microalbumin; 
uNAG, urinary N-acetyl-β-d-glucosamine-dase; 
UP24 h, urine protein for 24 h; VEGF, vascular 
endothelial growth factor; WT1, Wilms’ tumor 
1 gene; WT1EI, The expression index of Wilms 
tumor 1; XBP-1(s), spliced X box binding protein 
1; α-SMA, α-Alpha-smooth muscle actin; 8-OhdG, 
8-hydroxy-20-deoxyguanosine
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